In a study investigating HNSCC, Katada et al. found that the survival rate of patients with high plectin expression in their cancer cells was significantly decreased, and the frequency of recurrences significantly increased, compared to patients with low plectin expression [22]. This evidence concerns the gene PLEC and cancer.